GENEVA, Oct. 22 -- NGM BIOPHARMACEUTICALS, INC. filed a patent application (US2026/024121) for “CEACAM5 AND APLP2 BINDING AGENTS AND USES THEREOF”. With publication no. WO/2026/222361, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/40
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....